BRCA1 and breast carcinoma: Since most BRCA1-related breast carcinomas (heritable mutations or sporadic defects) are frequently triple negative cancers (reviewed in Diaz et al. [27]) with BRCA1 protein downregulation, EZH2 is most likely upregulated in these carcinomas.